Abstract:The heme oxygenase (HO) enzyme system catabolizes heme to carbon monoxide (CO), ferrous iron, and biliverdin-IXα (BV), which is reduced to bilirubin-IXα (BR) by biliverdin reductase (BVR). HO activity is represented by two distinct isozymes, the inducible form, HO-1, and a constitutive form, HO-2, encoded by distinct genes (HMOX1, HMOX2, respectively). HO-1 responds to transcriptional activation in response to a wide variety of chemical and physical stimuli, including its natural substrate heme, oxidants, and phytochemical antioxidants. The expression of HO-1 is regulated by NF-E2-related factor-2 and counter-regulated by Bach-1, in a heme-sensitive manner. Additionally, HMOX1 promoter polymorphisms have been associated with human disease. The induction of HO-1 can confer protection in inflammatory conditions through removal of heme, a pro-oxidant and potential catalyst of lipid peroxidation, whereas iron released from HO activity may trigger ferritin synthesis or ferroptosis. The production of heme-derived reaction products (i.e., BV, BR) may contribute to HO-dependent cytoprotection via antioxidant and immunomodulatory effects. Additionally, BVR and BR have newly recognized roles in lipid regulation. CO may alter mitochondrial function leading to modulation of downstream signaling pathways that culminate in anti-apoptotic, anti-inflammatory, anti-proliferative and immunomodulatory effects. This review will present evidence for beneficial effects of HO-1 and its reaction products in human diseases, including cardiovascular disease (CVD), metabolic conditions, including diabetes and obesity, as well as acute and chronic diseases of the liver, kidney, or lung. Strategies targeting the HO-1 pathway, including genetic or chemical modulation of HO-1 expression, or application of BR, CO gas, or CO donor compounds show therapeutic potential in inflammatory conditions, including organ ischemia/reperfusion injury. Evidence from human studies indicate that HO-1 expression may represent a biomarker of oxidative stress in various clinical conditions, while increases in serum BR levels have been correlated inversely to risk of CVD and metabolic disease. Ongoing human clinical trials investigate the potential of CO as a therapeutic in human disease.

Crosstalk between Heme Oxygenase-1 and Iron Metabolism in Macrophages: Implications for the Modulation of Inflammation and Immunity

Heme Oxygenase-1 Increases Intracellular Iron Storage and Suppresses Inflammatory Response of Macrophages by Inhibiting M1 Polarization.

The different facets of heme-oxygenase 1 in innate and adaptive immunity

Regulation of inflammation by the antioxidant haem oxygenase 1

Myeloid Heme Oxygenase-1 a New Therapeutic Target in Anti-Inflammation

The clinical relevance of heme detoxification by the macrophage heme oxygenase system

Heme Oxygenase-1: An Anti-Inflammatory Effector in Cardiovascular, Lung, and Related Metabolic Disorders

Heme Oxygenase-1 Signaling and Redox Homeostasis in Physiopathological Conditions

Heme Degradation in Pathophysiology of and Countermeasures to Inflammation-Associated Disease

Hypoxia And Heme Oxygenases: Oxygen Sensing And Regulation Of Expression

Heme Oxygenase-1 Couples Activation of Mitochondrial Biogenesis to Anti-inflammatory Cytokine Expression

Heme Oxygenase-1 as a Therapeutic Target in Neurodegenerative Diseases and Brain Infections

Role of Heme Oxygenase as a Modulator of Heme-Mediated Pathways

Heme Oxgenase-1, a Cardinal Modulator of Regulated Cell Death and Inflammation

The Role of Iron Homeostasis in Remodeling Immune Function and Regulating Inflammatory Disease

New insights into the links between hypoxia and iron homeostasis

Heme oxygenase 1 controls early innate immune response of macrophages to Salmonella Typhimurium infection

Hypoxia and Heme Oxygenases: Oxygen Sensing and Regulation of Expression.

Heme Oxygenase-1 in Macrophages Drives Septic Cardiac Dysfunction Via Suppressing Lysosomal Degradation of Inducible Nitric Oxide Synthase

[Progress on iron metabolism and ferroptosis in macrophages]

Ironing Out the Details: How Iron Orchestrates Macrophage Polarization